Objective-Inflammatory activation of valve endothelium is an early phase of aortic valve disease pathogenesis, but subsequent mechanisms are poorly understood. Adult valve endothelial cells retain the developmental ability to undergo endothelial-to-mesenchymal transformation (EndMT), but a biological role has not been established. Here, we test whether and how inflammatory cytokines (tumor necrosis factor-α and interleukin-6) regulate EndMT in embryonic and adult valve endothelium. Methods and Results-Using in vitro 3-dimensional collagen gel culture assays with primary cells, we determined that interleukin-6 and tumor necrosis factor-α induce EndMT and cell invasion in dose-dependent manners. Inflammatory-EndMT occurred through an Akt/nuclear factor-κB-dependent pathway in both adult and embryonic stages. In embryonic valves, inflammatory-EndMT required canonical transforming growth factor-β signaling through activin receptor-like kinases 2 and 5 to drive EndMT. In adult valve endothelium, however, inflammatory-induced EndMT still occurred when activin receptor-like kinases 2 and 5 signaling was blocked. Inflammatory receptor gene expression was significantly upregulated in vivo during embryonic valve maturation. Endothelial-derived mesenchymal cells expressing activated nuclear factor-κB were found distal to calcific lesions in diseased human aortic valves. Conclusion-Inflammatory cytokine-induced EndMT in valve endothelium is present in both embryonic and adult stages, acting through Akt/nuclear factor-κB, but differently using transforming growth factor-β signaling. Molecular signatures of valve EndMT may be important diagnostic and therapeutic targets in early valve disease. (Arterioscler Thromb Vasc Biol. 2013;32:121-130.)
D egenerative heart valve disease is a significant contributor to cardiovascular morbidity in the United States. Aortic valve dysfunction affects 2.5% of all Americans and 30% of the elderly. 1 Heart valve disease directly claims 20 000 lives annually in the United States, and sufferers have twice the risk of heart attacks, strokes, and heart failure. 1 In addition, congenital valve abnormalities affect 1% to 2% of live births and lead to early structural deterioration. 2 Historically, aortic valve disease (AVD) was thought to be pathogenically similar to vascular atherosclerosis. Both diseases are characterized by loss of endothelial integrity, infiltration of inflammatory cells, accumulation of plasma lipoproteins, release of inflammatory cytokines, mesenchymal proliferation, extracellular matrix remodeling, and the growth of plaque lesions. 3 Unlike atherosclerosis, however, AVD leads to large, obstructive lesions containing significant matrix mineralization. 4 Randomized clinical trials using lipid-lowering agents to halt AVD severity or progression have been disappointing. 5, 6 These findings underscore the conclusion that mechanisms of AVD are distinctly different from vascular atherosclerosis. As a consequence, there are currently no established molecular biomarkers specific to AVD progression and no molecular targets for AVD therapy. 7 We previously determined in mice that the degree of inflammation in aortic valves directly correlates with the degree of calcification. 8 Diseased human valve cusps become progressively thickened, with increases in the presence of macrophages and cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). [9] [10] [11] Both IL-6 and TNF-α can activate arterial endothelial cells, which is a phenotypic change characterized by upregulation of adhesion molecules, such as intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion protein 1 (VCAM-1), recruitment of leukocytes, and increased monolayer permeability. 10, 12, 13 In atherosclerotic plaques, both IL-6 and TNF-α drive transcription through nuclear translocation of nuclear factor-κB (NFκB), but their role in valve endothelium is unknown. 14, 15 Fetal human aortic valve endothelial cells also express ICAM-1 and VCAM-1, which suggests that endothelial activation also occurs during valve development. 16 TNF-α, IL-6, and NFκB expression levels are elevated in the myocardium of children with congenital heart defects affecting valve development. 17, 18 NFκB inhibition during avian heart development leads to valvuloseptal defects and impaired outlet formation. 19 Leptin, a member of the IL-6 superfamily, was shown to induce endothelial-to-mesenchymal transformation (EndMT) in embryonic endocardium, in part through activating transforming growth factor-β (TGF-β). 20 Akt has also been shown to drive embryonic and adult EndMT. 21, 22 Adult ovine aortic valve endothelium has been shown to undergo EndMT in vitro and in vivo. [23] [24] [25] Collectively, these findings motivate the hypothesis that inflammatory signaling toward EndMT may be a developmentally conserved signaling pathway in valve endothelium, but a biological rationale is unclear.
In this study, we determine that both TNF-α and IL-6 induce EndMT in embryonic and adult valve endothelium via an Akt/ NFκB-dependent pathway. In embryonic valve endocardium, NFκB acted upstream of TGF-β to induce EndMT through activin receptor-like kinases 2 and 5 (Alk2/5). We found increasing levels of TNF-α and IL-6 receptor gene expression in embryonic valve primordia during valve morphogenesis. Interestingly, although TGF-β could drive EndMT in adult valve endothelium through Alk2/5, TGFβ was not required for NFκB-induced EndMT. Finally, we identify evidence of EndMT in calcified human aortic valves. Taken together, these findings support a developmentally conserved mechanism of valve remodeling via NFκB-induced EndMT that may be a previously unrecognized molecular signature of early AVD.
Materials and Methods
We used 2 well-characterized valve endothelial cell culture systems to test inflammatory signaling on EndMT in vitro: porcine aortic valve endothelial cells (PAVEC) and embryonic quail endocardial explants (QEE). [26] [27] [28] Additional details for each source are given in the online-only Data Supplement. PAVEC were isolated through collagenase digestion as previously described, 29 with purity confirmed via nondetection of the mesenchymal ACTA2 gene expression (>37 cycles via real-time polymerase chain reaction). PAVEC (<passage 5) were cultured as confluent surface monolayers on the surface of type 1 collagen hydrogels (1.5 mg/mL, 50 000 cells/cm 2 ). Pretransformed (HH14staged) QEE from the atrioventricular and outflow tract valvulogenic regions were cultured as monolayer patches (without myocardium) on 1.5 mg/mL collagen gels, as previously described. 27 EndMT was quantified via real-time polymerase chain reaction (RT-PCR), immunohistochemistry, and Western blotting, whereas cell invasion was quantified at 60 μm depth with brightfield microscopy ( Figure I in the online-only Data Supplement). The protein extraction and Western blot protocols are described in detail in the online-only Data Supplement. NFκB protein nuclear colocalization was quantified for 100 cells for each treatment using Metamorph 7.1 software (Molecular Devices, Sunnyvale, CA). RNA extraction, purification, and RT-PCR were performed according to the manufacturer's protocols. Primers used for RT-PCR are listed in Table I in the online-only Data Supplement. For NFκB transfection, PAVEC were trypsinized and electroporated with plasmid encoding the RelA subunit of NFκB (Addgene plasmid 23255) using Neon transfection system (Invitrogen, Carlsbad, CA) and further cultured in 5% serum, antibiotic-free DMEM for 24 hours. 30 The cells were then trypsinized, resuspended in normal media (DMEM with 10% fetal bovine serum and 1% penicillin-streptomycin), and seeded onto gels. Invasion assay was performed as described above. Human diseased aortic valves were obtained from adults undergoing planned, nonelective valve replacement surgery by Dr Sanjay Samy at Robert Packer Hospital in Sayer, PA. All procedures were approved by Institutional Review Boards at Cornell and Robert Packer Hospital. Pediatric valves were obtained from Dr Jonathan Chen, Cornell-Weill Medical School and NY Presbyterian Hospital. Results are expressed as mean±SEM, n≥3 independent cultures per treatment condition, with 5 to 6 explants pooled for each QEE sample. Data were analyzed with GraphPad Prism version 4 for Windows (GraphPad Software, San Diego, CA). Treatment effects were compared using ANOVA with Tukey post hoc paired tests, and data were transformed when necessary to obtain equal sample variances. Differences between means were considered significant at P≤0.05. Expanded methods are provided in the online-only Data Supplement.
Results

TNF-α and IL-6 Induce EndMT in Adult Valve Endothelial Cells
We first exposed 3-dimensional (3D), cultured, adult PAVEC monolayers to doses of TNF-α or IL-6 and quantified changes in EndMT-related gene expression, protein expression, and collagen matrix invasion. Both IL-6 and TNF-α in 3D culture induced loss of endothelial cell-cell contacts, including platelet endothelial cell adhesion molecule-1 (PECAM-1) and vascular endothelial-cadherin (VE-cadherin), acquisition of mesenchymal α-smooth muscle actin (α-SMA), and invasion into collagen matrix in a dose-dependent manner ( Figure  1A , 1D, 1E, and 1G; Figures I and II in the online-only Data Supplement). Genetic overexpression of NFκB alone was sufficient to cause 3D matrix invasion in PAVEC, supporting an NFκB-dependent EndMT mechanism ( Figure 1A ). Pro-EndMT-related gene expression (ACTA2, Snail, TGFβ1) was significantly upregulated in response to NFκB overexpression (238±20.6, 15.0±1.1, and 4.2±0.5 fold, respectively) and TNFα (14.3±4.8, 3.8±0.7, and 3.8±0.6 fold, respectively; P<0.05), but not IL-6 ( Figure 1B ). EndMT-related protein expression (α-SMA, Snail increase, and VE-cadherin decrease) was shown in PAVEC, but not porcine aortic endothelial cells (PAEC), in response to TNF-α ( Figure 1G ). TGF-β1, however, induced EndMT protein expression in both PAVEC and PAEC ( Figure  1G ). Nuclear translocation of NFκB was significantly upregulated in response to either IL-6 or TNF-α (1.7±0.1 and 2.0±0.1 fold increase, respectively; P<0.05; Figure 1C and 1F; Figure  III in the online-only Data Supplement). To control for cell number, we quantified PAVEC proliferation (via BrdU incorporation) and apoptosis (via TUNEL) in response to doses of TNF-α. PAVEC proliferation increased with TNF-α dose (up to 2.7±0.1 at 100 ng/mL; P<0.05; Figure ID in the online-only Data Supplement), whereas apoptosis remained unchanged (Supplemental Figure IE) . Collectively, these results suggest that IL-6 and TNF-α induce EndMT and matrix invasion in adult PAVEC in vitro, at least in part through NFκB, with TNFα being a more potent EndMT inducer.
EndMT Is Present in Calcified Human Aortic Valves
In explanted human aortic valves with calcific lesions ( Figure 1G-1I ), we identified a population of subendothelial cells coexpressing α-SMA and PECAM-1, but not (IL-6), 100 ng/mL tumor necrosis factor-α (TNF-α), or genetic overexpression of nuclear factor-κB (NFκB). B, PAVEC endothelial-to-mesenchymal transformation (EndMT)-related gene expression after 48-hour exposure to 100 ng/mL IL-6 or TNF-α, or genetic overexpression of NFκB. C, PAVEC NFκB nuclear localization quantification. D, Confocal images of control, +100 ng/mL IL-6, and +100 ng/mL TNF-α PAVEC at a 48-hour time point stained for CD31 (red), α-smooth muscle actin (α-SMA; green), and DNA (blue). E, Confocal images of control, +100 ng/mL IL-6, and +100 ng/mL TNF-α PAVEC at a 48-hour time point stained for vascular endothelial (VE)-cadherin (red), α-SMA (green), and DNA (blue). F, Confocal images of control, +100 ng/mL IL-6, and +100 ng/mL TNF-α PAVEC at a 48-hour time point stained for NFκB (green) and DNA (blue). G, Western blots for PAVEC and porcine aortic valve endothelial cells exposed to 100 ng/mL TNF-α or transforming growth factor-β1 (TGF-β1) for 48 hours. H, Diseased human aortic valve endothelial cells coexpressing α-SMA and CD31 (on the fibrosa or outflow side and invaded, calcified nodule shown in inset). I, Expanded frame of H. J, Nuclear translocation of NFκB in diseased human valve endothelial cells. Error bars show ±SEM, n≥3 culture wells. Bars that do not share any letters are significantly different according to a 1-way ANOVA with Tukey posttest (P≤0.05). For EndMT gene expression (B), differences that are significantly different than the control according to an unpaired Student t test are indicated with an *. Differences were considered significant at P≤0.05. Scale bars, 25 μm (D and E) or 10 μm (F). PECAM indicates platelet endothelial cell adhesion molecule; PAEC, porcine aortic endothelial cells; VEcadherin, vascular endothelial-cadherin; TGF-β1, transforming growth factor-β1. This suggests the cells were EndMT-derived, but not from an immune origin. 31 The number of invaded fibrosal endothelial cells was 11.13±1.88 cells/×40 field (scanning confocal microscopy, n=3 calcified adult valves). Endothelial cells located near the calcified nodule and on the fibrosa side showed decreased VE-cadherin expression ( Figure IVD in the online-only Data Supplement). EndMT and potential EndMT-derived cells were only found in the fibrosa layer, distal to sites of calcified lesions. Furthermore, we found that many of these transformed and invaded cells also coexpressed nuclear NFκB ( Figure 1H ). Healthy pediatric human valves did not coexpress α-SMA and VE-cadherin or nuclear NFκB (Figures V and VI in the online-only Data Supplement). These findings support that NFκB-mediated EndMT occurs in human calcific AVD but is likely not involved in the mineralization process.
TNFα and IL-6 Induce EndMT in Embryonic Valve Endocardium
Similarly, we quantified the EndMT response characteristics of 3D-cultured HH14pretransformed QEE monolayers from outflow tract or atrioventricular regions to doses of TNF-α and IL-6. As in adult valve endothelium, both IL-6 and TNFα induced loss of QH1, acquisition of α-SMA, and collagen matrix invasion (Figure 2A and 2D). Embryonic endocardial EndMT-related genes (ACTA2, Slug, and TGFβ3) were significantly upregulated in valvulogenic endocardium by both IL-6 and TNF-α ( Figure 2B ). PECAM1 gene expression was significantly increased in response to inflammatory cytokine (Figure 2A ). PECAM1 has been shown to be an early marker of cardiovascular development, and the increase in PECAM1 in culture is likely related to embryonic endocardial differentiation. 32 Downstream NFκB protein nuclear translocation also occurred in response to either IL-6 or TNF-α ( Figure 2C and 2E; Figure VII in the online-only Data Supplement). There was no difference in explant area (a control for cell number) with IL-6 or TNF-α stimulation compared with control ( Figure VIIIC and VIIID in the online-only Data Supplement).
Collectively, these results suggest that both TNF-α and IL-6 induce EndMT in embryonic valve endocardial cells in vitro with similar potency. We further quantified the expression of inflammatory signaling-related genes in the atrioventricular and outflow tract valve, forming regions of embryonic hearts across the period of valve morphogenesis (day 2 to day 10). We determined that ICAM-1, NFκB-1, IL-6RA (coding for 
Inflammatory-EndMT Acts Through an Akt/NFκB Pathway Present in Both Adult and Embryonic Valve Endothelium
We next sought to identify the signaling pathway by which inflammatory cytokines induced EndMT through NFκB. Previous studies have shown that TNF-α activates NFκBmediated transcription through Akt or mitogen-activated protein kinase kinase 1 (MEK1). [33] [34] [35] [36] [37] IL-6 activates signal transducer and activator of transcription 3 (STAT3) most potently, but there is also evidence of IL-6-induced NFκB activation through phosphoinositide 3-kinase (PI3K) and Akt. [38] [39] [40] [41] Using our 3D culture system, molecular inhibition of either Akt (via 5 μm Akt inhibitor XI) or MEK1 (via 25 μm PD98059) significantly reduced TNF-α-induced NFκB expression and nuclear translocation in PAVEC, but only Akt inhibition resulted in complete knockdown ( Figure 3C and 3D). Akt inhibition also completely blocked IL-6induced NFκB gene expression and protein nuclear translocation, whereas STAT3 inhibition (via 5 μm PpYLKTK STAT3 inhibitor) had no effect ( Figure XC and XD in the online-only Data Supplement). Inhibition of Akt completely blocked TNF-α-induced inflammatory receptor activation (VCAM-1, ICAM-1), EndMT-associated gene expression (ACTA2, Snail, TGFβ1), and subsequent matrix invasion by PAVEC ( Figure 3A-3C ). MEK1 blockade also inhibited TNF-α-induced inflammatory receptor activation, EndMT gene expression, and subsequent invasion, but to a lesser degree than Akt inhibition. In a similar fashion, Akt inhibition completely blocked IL-6-induced upregulation of inflammatory receptors, EndMT gene expression, and subsequent matrix invasion (Figure XA-XC in the online-only Data Supplement). STAT3 inhibition, however, had no effect on any of these responses from IL-6.
Identical experiments were conducted on avian pre-EndMT valvulogenic endocardial monolayers. As in adult valve endothelium, molecular inhibition of Akt or MEK1 both blocked TNF-α-induced NFκB gene expression and nuclear translocation. Akt inhibition completely blocked NFκB, whereas MEK1 inhibition only partially blocked NFκB (Figure 4C  and 4D ). IL-6-induced NFκB gene expression and protein nuclear translocation were also blocked with Akt inhibition but not STAT3 inhibition ( Figure XIC Collectively, these results suggest that inflammatory cytokines initiate EndMT at the gene, protein, and function levels through an AKT/NFκB pathway that is conserved in both adult valve endothelial and embryonic valvulogenic endocardium. TNF-α was a more potent inducer of EndMT and resulted in more consistent pathway responses in both cell types compared with IL-6. IL-6 may also induce EndMT genes more strongly at an earlier or later time point.
TGF-β Signaling Through Alk2/5 Is Required for Inflammation-Induced Embryonic EndMT, But Not for Adult EndMT
Previous studies have identified a canonical TGF-β signaling pathway that induces EndMT and is isoform-specific: the 
TGF-β1 isoform in adult valve endothelial cells, whereas End
MT invasion is mediated by TGF-β3 in avian embryonic valve endocardium. 23, 42, 43 We therefore tested whether TGF-β signaling was involved in inflammatory-induced EndMT. As a positive control, exogenous TGF-β3 (100 ng/mL) induced EndMT matrix invasion in embryonic valve endocardium ( Figure 5A Figure  2B ). Previous studies demonstrate that TGF-β type I Alk2/5 mediate TGF-β-induced EndMT. 44, 45 Molecular inhibition of Alk2/5 signaling (via 10 μm SB 431542) in QEE reduced EndMT-related gene expression ( Figure 5B ; Figure Figure 5E ), but did not affect inflammatory activation-related gene expression ( Figure 5C ; Figure  XVC in the online-only Data Supplement) or NFκB protein nuclear localization ( Figure 5D ; Figure XVD in the onlineonly Data Supplement). Together, these results support that inflammatory cytokine-induced EndMT in embryonic valves acts at least in part by canonical TGF-β-Alk-Smad signaling that is downstream of NFκB.
In contrast to embryonic valve endocardium, Alk2/5 inhibition in adult valve endothelial cells (PAVEC) treated with TNF-α significantly decreased Smad2/3 phosphorylation and nuclear translocation ( Figure 6E ), but did not result in decreased cell invasion ( Figure 6A) , did not effect EndMTrelated or inflammatory activation-related gene expression ( Figure 6B and 6C) , and did not inhibit NFκB nuclear localization ( Figure 6D ). Interestingly, endothelial cells from the porcine aorta show increased pSmad2 in response to TGF-β1, but not to TNF-α treatment, suggesting a unique signaling behavior of PAVEC in response to TNF-α ( Figure 6F) . These results suggest that Alk2/5-dependent TGF-β signaling is not downstream of TNF-α-induced EndMT in adult valve endothelium. Therefore, although both embryonic and adult valve endothelium activate an EndMT program in response to TNFα through Akt/NFκB, TGF-β signaling is required downstream in embryonic but not in adult valve endothelium. Adult cells may bypass TGF-β signaling because activated NFκB has been shown to stabilize Snail, an EndMT-regulating transcription factor, in adult cells. 46 In mouse cardiac endothelial cells, treatment with SB431542, but not PD98059, completely blocked TGF-β2-induced EndMT. 47
Discussion
The molecular and cellular events that initiate and propagate AVD are poorly understood and are understudied, particularly with respect to endothelial dysfunction. Although the occurrence of EndMT has been previously noted in adult valve endothelium, a biological role remains unclear. EndMT studies in embryonic valves have identified >100 different regulatory genes, including members of the TGF-β, bone morphogenetic protein, and vascular endothelial growth factor signaling pathways and matrix proteins, such as periostin and versican. [48] [49] [50] [51] Misexpression and mutation of many of these genes have been identified in diseased aortic valves. 3 Our results identify a novel, inflammatory cytokine-induced EndMT pathway in aortic valve endothelium through Akt/NFκB and further support that this pathway is conserved during embryonic valve development. These findings collectively suggest that an inflammatory reactivation of embryonic-like EndMT may be a mechanism of early aortic valve dysfunction.
Identifying mechanisms conserved between embryonic and adult valve endothelium remains challenging because there is currently no species for which both embryonic and adult valve endothelial cell cultures have been obtained. Porcine aortic valve endothelial cells are the well-characterized and well-studied adult valve endothelial population and can be obtained from animals without disease. 29, [52] [53] [54] Human aortic valve endothelial cells have been obtained from recipient hearts from cardiac transplantation surgeries or rejected valve donors. Although no gross calcification may be present, the valve endothelium exhibits non-negligible inflammatory activation [55] [56] [57] [58] Paruchuri et al 59 identified clonally isolated subpopulations of human pulmonary valve endothelial cells that were capable of EndMT in response to TGF-β, which supports our findings in pure, whole valve endothelial cells populations. Holliday et al recently showed that in vitro cultured human aortic valve endothelial cells isolated from heart transplant surgeries express endothelial phenotype markers and elevated α-SMA, which is in contrast to in vivo expression patterns in nondiseased human and porcine aortic valves. 16, [60] [61] [62] These coexpression findings suggest that human aortic valve endothelium from these patients may have an increased propensity or capacity for EndMT. 60 Furthermore, several studies demonstrate that inflammatory endothelial activation and calcific degeneration occur preferentially on the fibrosa side of the valve. 4, 63, 64 Our analysis of calcified human aortic valves found invaded cells coexpressing α-SMA and CD31 on the fibrosa surface, suggesting that EndMT correlates with side-specific propagation of AVD. 65 In situ mRNA profiling of valve endothelial cells determined hundreds of genes that are differently expressed between sides, with many further modified in experimental hypercholesteremia. 52, 53 The inflow or ventricularis surface is exposed to pulsatile unidirectional shear stress, whereas the outflow or fibrosa surface experiences oscillatory shear stress. 65 When either endothelial surface is exposed to opposite-sided flow profiles, they similarly upregulate inflammatory receptors. 66 Recently, Wu et al 67 demonstrated that both sides of valve endothelium have the same genetic origin. Our results support and extend these findings to suggest that fibrosa-sided environmental conditions are more conducive to inflammatory activation and EndMT, but additional studies on side-specific endothelial populations are warranted.
Cellular and molecular analysis of embryonic valve formation is almost exclusively conducted with avian and mouse models. Although there are some differences in cardiac anatomy between avians and mammals, the morphogenesis, remodeling, and final anatomy of the clinically important left side of the heart are more similar between chicks and humans than in mice. [68] [69] [70] [71] Biological assays with avian and mouse valve progenitors demonstrate identical molecular mechanisms and participants, although the isoforms used may differ. 72, 73 Importantly, chick embryos are inexpensive, can be obtained without additional animal euthanization, and are very tolerant of experimentation. Our findings of progressive upregulation of inflammatory receptors in valve formation in embryonic chicks are supported by observations in fetal human aortic valves. 16 Our result that EndMT and matrix invasion occurs at least through TGF-β1 in adult porcine cells and TGF-β3 in embryonic quail is supported by several studies. 23, 43 Therefore, we have confidence that the general molecular regulation we identify is likely conserved across age, but we cannot definitively rule out species differences in the isoforms used.
The downstream fate of EndMT-derived mesenchyme in adult valves is of great interest, but was not a focus of this study. Bischoff and Aikawa 74 recently proposed that EndMT creates a type of progenitor-like cell that renews the valve interstitial cell population and maintains tissue homeostasis. Both embryonic and adult valvular mesenchymal cells have the potential for osteogenic differentiation, 75, 76 but whether these cells are directly EndMT-derived or from subsequent differentiation processes is not yet known. TNF-α and NFκB have been linked to the mesenchymal cell molecular and cellular mechanisms that mediate valvular calcification. 9,77 TNF-α expression and nuclear localization of NFκB are present in stenotic human aortic valves, 78 and TNF-α treatment of valve interstitial cells in 2-dimensional culture induces calcium nodule formation and expression of runx2, independent of osteogenic media. 9,79, 80 We found EndMT-derived subendothelial cells in calcified human aortic valves but were always located distal to calcific lesions. This was not unexpected, because valve calcifications are associated with endothelial loss. 81 Taken together, these results support that inflammatory EndMT is a component of early stage AVD, but how these progeny contribute to and regulate downstream calcific progression is still unclear.
In conclusion, our results establish an inflammatory mechanism of early aortic valve pathogenesis that is, in part, developmentally conserved. Age-dependent use of canonical TGF-β signaling may be an important mode of inflammatory disease pathogenesis distinct from potentially healthy tissue formation and remodeling. Selective molecular inhibition of the AKT/NFκB pathway in valve endothelium may therefore be a potential strategy for impacting early stage AVD. Figure 6 . Adult cells do not require transforming growth factor-β (TGF-β) in inflammatory-endothelial-to-mesenchymal transformation (EndMT) signaling. A, Cell invasion after a 48-hour exposure to 100 ng/mL TGF-β1, 100 ng/mL tumor necrosis factor-α (TNF-α), or 100 ng/mL TNF-α with 10 μm SB 431542 activin receptor-like kinase 5 (Alk5) inhibitor. B, EndMT-related gene expression after a 48-hour exposure to 100 ng/mL TNF-α with inhibitors. C, Inflammatory activation-related genes after a 48-hour exposure to 100 ng/mL TNF-α with inhibitors. D, Porcine aortic valve endothelial cell (PAVEC) nuclear factor-κB (NFκB) nuclear localization quantification after a 48-hour exposure to 100 ng/mL TNF-α with inhibitors. E, pSMAD2/3 nuclear localization after a 48-hour exposure to 1 ng/mL TGF-β1, 100 ng/mL TNF-α, or 100 ng/ mL TNF-α with 10 μm SB 431542 ALK5 inhibitor. Staining shows pSMAD2/3 (green) or DNA (blue). F, Western blots for PAVEC or porcine aortic endothelial cells (PAEC) exposed to 100 ng/mL TNF-α or TGF-β1 for 48 hours. Error bars show ±SEM, n≥3 culture wells with monolayers. Bars that do not share any letters are significantly different according to a 1-way ANOVA with Tukey posttest (P≤0.05). VCΑΜ-1 indicates vascular cell adhesion protein 1; and ΙCAM-1, intercellular adhesion molecule 1. (No. 0830384N) , and the LeDucq Foundation (Project MITRAL).
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